Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1987 1
1988 1
1990 1
1993 1
1995 3
1996 2
1998 6
1999 6
2000 1
2001 1
2002 1
2003 3
2004 5
2005 3
2006 6
2007 2
2008 3
2009 2
2010 1
2011 3
2012 1
2014 2
2016 2
2018 1
2020 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Use of Dupilumab in Glucocorticoid-Dependent Asthma.
Mamilla M, Maddeti NY, Thada PK, Mahamoud I, Sarwar S, Waleed MS, Yadav S, Mustansir M, Raut A, Yatzkan G, Perez-Fernandez J. Mamilla M, et al. South Med J. 2022 Aug;115(8):611-615. doi: 10.14423/SMJ.0000000000001423. South Med J. 2022. PMID: 35922047 Review.
There is a broad range of drugs used for asthma; the most used medications for severe asthma are inhaled glucocorticoids with or without long-acting beta-agonists. ...Our review of the literature indicates that dupilumab has proven to improve lung function, r …
There is a broad range of drugs used for asthma; the most used medications for severe asthma are inhaled glucocorticoid …
Safety of intranasal corticosteroids.
Bensch GW. Bensch GW. Ann Allergy Asthma Immunol. 2016 Dec;117(6):601-605. doi: 10.1016/j.anai.2016.06.009. Ann Allergy Asthma Immunol. 2016. PMID: 27979016 Review.
BACKGROUND: Concurrent use of intranasal corticosteroids (INCSs) and inhaled corticosteroids (ICSs) is indicated for patients who are comorbid for asthma and allergic rhinitis. Clinicians need to know the data regarding INCS safety for their patients w …
BACKGROUND: Concurrent use of intranasal corticosteroids (INCSs) and inhaled corticosteroids (ICSs) is indicated for pa …
Cataract and ocular hypertension in children on inhaled corticosteroid therapy.
Behbehani AH, Owayed AF, Hijazi ZM, Eslah EA, Al-Jazzaf AM. Behbehani AH, et al. J Pediatr Ophthalmol Strabismus. 2005 Jan-Feb;42(1):23-7. doi: 10.3928/01913913-20050101-03. J Pediatr Ophthalmol Strabismus. 2005. PMID: 15724895
Only 3 (3%) patients had cortical changes that were not visually significant, and none had posterior subcapsular or nuclear cataract. There was no significant differences between children with cataract and those without cataract with respect to age; duration …
Only 3 (3%) patients had cortical changes that were not visually significant, and none had posterior subcapsular or nuclear cataract. …
Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology.
Leone FT, Fish JE, Szefler SJ, West SL. Leone FT, et al. Chest. 2003 Dec;124(6):2329-40. doi: 10.1378/chest.124.6.2329. Chest. 2003. PMID: 14665517 Review.
INTRODUCTION: The available clinical guidelines have been successful in improving awareness of the inflammatory nature of asthma and have promoted the use of inhaled corticosteroids (ICSs) to achieve long-term control of symptoms. ...
INTRODUCTION: The available clinical guidelines have been successful in improving awareness of the inflammatory nature of asthma and …
Inhaled corticosteroids and cataract: prevalence, prevention and management.
Cumming RG, Mitchell P. Cumming RG, et al. Drug Saf. 1999 Jan;20(1):77-84. doi: 10.2165/00002018-199920010-00007. Drug Saf. 1999. PMID: 9935278 Review.
Oral and topical (ocular) corticosteroids are known to have the potential to cause cataracts, but inhaled corticosteroids have generally been considered to be free of this adverse effect. ...For people with asthma, the benefits of inhaled …
Oral and topical (ocular) corticosteroids are known to have the potential to cause cataracts, but inhaled corticoste …
Updates on the use of inhaled corticosteroids in asthma.
Stoloff SW, Kelly HW. Stoloff SW, et al. Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):337-44. doi: 10.1097/ACI.0b013e328348a813. Curr Opin Allergy Clin Immunol. 2011. PMID: 21720220 Review.
PURPOSE OF REVIEW: The purpose of this review is to compare and contrast the newer inhaled corticosteroid (ICS) ciclesonide with older ICSs in terms of pharmacodynamic and pharmacokinetic properties and how these affect comparative efficacy. ...Long-term administ …
PURPOSE OF REVIEW: The purpose of this review is to compare and contrast the newer inhaled corticosteroid (ICS) ciclesonide wi …
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review.
Patel R, Naqvi SA, Griffiths C, Bloom CI. Patel R, et al. BMJ Open Respir Res. 2020 Dec;7(1):e000756. doi: 10.1136/bmjresp-2020-000756. BMJ Open Respir Res. 2020. PMID: 33268342 Free PMC article.
We sought to understand if inhaled corticosteroid (ICS) use in asthma is also associated with increased risk of systemic effects. ...The one study which assessed ocular disorders found an increased risk of cataracts. Most studies were not able to fully …
We sought to understand if inhaled corticosteroid (ICS) use in asthma is also associated with increased risk of systemi …
Use of inhaled and oral corticosteroids and the long-term risk of cataract.
Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P. Wang JJ, et al. Ophthalmology. 2009 Apr;116(4):652-7. doi: 10.1016/j.ophtha.2008.12.001. Epub 2009 Feb 25. Ophthalmology. 2009. PMID: 19243828
OBJECTIVE: Longitudinal associations between inhaled and oral corticosteroid use and 10-year incident cataract were examined. ...Interaction between inhaled and oral corticosteroid use was significant for PSC (P = 0.01) and nuclear (P = 0.02) …
OBJECTIVE: Longitudinal associations between inhaled and oral corticosteroid use and 10-year incident cataract were exa …
Defining the effects of an inhaled corticosteroid and long-acting beta-agonist on therapeutic targets.
Settipane RA; National Asthma Education and Prevention Program (NAEPP). Settipane RA, et al. Allergy Asthma Proc. 2003 Mar-Apr;24(2):85-9. Allergy Asthma Proc. 2003. PMID: 12776440 Review.
The effects of inhaled corticosteroids (ICSs) and long-acting beta 2-agonists (LABAs) on therapeutic targets have significant clinical relevance regarding optimal management of asthma. ...Consequently, this combination is the preferred choice for treating mod …
The effects of inhaled corticosteroids (ICSs) and long-acting beta 2-agonists (LABAs) on therapeutic targets have significant …
Comorbidity Burden in Severe and Nonsevere Asthma: A Nationwide Observational Study (FINASTHMA).
Kankaanranta H, Viinanen A, Ilmarinen P, Hisinger-Mölkänen H, Mehtälä J, Ylisaukko-Oja T, Idänpään-Heikkilä JJ, Lehtimäki L. Kankaanranta H, et al. J Allergy Clin Immunol Pract. 2024 Jan;12(1):135-145.e9. doi: 10.1016/j.jaip.2023.09.034. Epub 2023 Oct 4. J Allergy Clin Immunol Pract. 2024. PMID: 37797715 Free article.
OBJECTIVE: In this cross-sectional study, we analyzed the comorbidity burden in patients with severe asthma compared with nonsevere asthma and investigated the role of corticosteroid use on the risk of comorbidities. ...Asthma was defined as continuous …
OBJECTIVE: In this cross-sectional study, we analyzed the comorbidity burden in patients with severe asthma compared with nonsevere …
64 results